Cannula Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Type, By Material, By Size, By End-Use Industry, By Region & Competition, 2021-2031F

Description

The Global Cannula Market is projected to expand from USD 226.59 Million in 2025 to USD 357.78 Million by 2031, exhibiting a CAGR of 7.91%. Defined as flexible tubes typically containing retractable inner cores, cannulas are essential for fluid drainage or medication administration within bodily cavities or vessels. The industry is primarily propelled by the increasing prevalence of chronic diseases requiring prolonged intravenous therapy and an aging population, which leads to higher hospitalization rates. Additionally, the widespread adoption of minimally invasive medical techniques mandates the consistent use of these devices for accurate vascular access and fluid management, ensuring a stable demand trajectory beyond temporary market shifts.

Market Overview
Forecast Period	2027-2031
Market Size 2025	USD 226.59 Million
Market Size 2031	USD 357.78 Million
CAGR 2026-2031	7.91%
Fastest Growing Segment	Cardiac
Largest Market	North America

Despite these growth factors, the danger of catheter-related bloodstream infections constitutes a major obstacle, leading to tighter regulatory controls and increased healthcare expenses. This urgent necessity for safer vascular access solutions is reinforced by significant disease burden metrics; according to the American Heart Association's most recent comprehensive data from 2025, cardiovascular disease was responsible for roughly 19.41 million deaths worldwide, highlighting the massive volume of patients needing medical care.

Market Driver

The increasing popularity of aesthetic and cosmetic procedures has become a crucial catalyst for the global cannula market, particularly driving the use of blunt-tip microcannulas. These specialized instruments are being chosen over conventional hypodermic needles for soft tissue filler applications because they reduce patient bruising, alleviate pain, and significantly decrease the risk of vascular occlusion. This transition is supported by the rapid growth of the non-invasive sector; as per the International Society of Aesthetic Plastic Surgery's 'Global Survey 2024 Press Release' from June 2025, non-surgical interventions rose to approximately 20.5 million procedures globally. Consequently, manufacturers are compelled to develop flexible, safety-focused designs for facial contouring, establishing a lucrative niche within the vascular access market.

Concurrently, the escalating global incidence of chronic lifestyle and respiratory conditions demands sustained therapeutic interventions, securing the market's foundational volume. Diseases like diabetes and chronic obstructive pulmonary disease (COPD) necessitate frequent drug administration or continuous oxygen therapy, maintaining the requirement for superior intravenous and nasal cannulas. For example, the International Diabetes Federation's 'IDF Diabetes Atlas 11th Edition' in 2025 estimated that 589 million adults worldwide were living with diabetes, representing a demographic heavily dependent on insulin delivery mechanisms. This extensive disease burden guarantees reliable revenue for medical device firms; ICU Medical reported in their 'Third Quarter 2025 Financial Results' in November 2025 that quarterly revenues hit roughly $537 million, illustrating the persistent demand for vital infusion and critical care supplies.

Market Challenge

The ongoing threat of catheter-related bloodstream infections and complications associated with vascular access remains a significant hurdle to the Global Cannula Market's progress. This safety issue severely limits market growth by necessitating strict regulatory supervision and increasing liability risks for healthcare providers. As regulators implement more rigorous safety protocols to address these dangers, manufacturers must dedicate substantial resources to compliance and quality assurance, which drives up production costs and prolongs approval periods for new devices. These financial and procedural challenges establish high entry barriers and retard the launch of innovative products, effectively constraining the overall speed of market evolution.

The gravity of this challenge is emphasized by the high incidence of device-related failures in clinical environments. According to data from the Association for Vascular Access in 2024, the failure rate of peripheral intravenous catheters in hospitalized patients fell between 35% and 50%. Such a high rate of failure compels medical institutions to direct considerable funds toward managing complications and conducting re-insertion procedures. As a result, hospitals frequently employ conservative purchasing strategies that favor thorough validation over high volume, which directly inhibits the rapid uptake and global volume expansion of cannula products.

Market Trends

Healthcare institutions are increasingly standardizing the adoption of safety IV cannulas featuring automatic needle-shielding technology to reduce occupational risks. This movement is a direct reaction to more stringent safety regulations designed to eliminate needle-stick injuries among medical staff and prevent cross-contamination during vascular access processes. In response, manufacturers are significantly scaling up production capacities to satisfy this regulation-led demand for protective equipment. According to a January 2025 press release titled 'BD Boosts U.S. Manufacturing of Critical Medical Devices,' Becton, Dickinson and Company announced investments to increase their manufacturing capacity for safety-engineered injection devices by over 40 percent to support essential healthcare delivery requirements.

At the same time, there is a clear transition toward developing user-friendly cannulas tailored for home-based care, especially regarding respiratory therapy and long-term infusion. As medical care shifts from hospital settings to patients' homes, there is a rising demand for durable, low-maintenance devices that enable individuals to independently manage chronic issues such as sleep apnea and respiratory distress. This shift toward home care is driving significant revenue increases for specialized device makers. As noted in Fisher & Paykel Healthcare's 'Annual Report 2025' from May 2025, revenue for their Homecare product group, which includes devices for community-based respiratory support, hit approximately $740 million, marking a 13% rise over the prior financial year.

Key Market Players

Medtronic plc
Becton Dickinson (BD) & Company
Edward Lifesciences Corporation
LivaNovaca plc
Smiths Medical MD Inc
Boston Scientific Corporation
Hindustan Syringes and Medical Devices Ltd (HMD)
Sterimedix Ltd.
Angiplast Pvt. Ltd
Sterimed Group

Report Scope

In this report, the Global Cannula Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cannula Market, By Product

Cardiac
Dermatology
Nasal
Others

Cannula Market, By Type

Neonatal Cannulae
Straight Cannulae
Winged Cannulae
Wing With Port
Winged With Stop Cork

Cannula Market, By Material

Plastic
Metal
Silicone

Cannula Market, By Size

Cannula Market, By End-Use Industry

Hospital
Ambulatory Surgical Centers
Others

Cannula Market, By Region

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cannula Market.

Available Customizations:

Global Cannula Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cannula Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Product (Cardiac, Dermatology, Nasal, Others)
- 5.2.2. By Type (Neonatal Cannulae, Straight Cannulae, Winged Cannulae, Wing With Port, Winged With Stop Cork)
- 5.2.3. By Material (Plastic, Metal, Silicone)
- 5.2.4. By Size (14G, 16G, 18G, 20G, 22G, 24G, 26G)
- 5.2.5. By End-Use Industry (Hospital, Ambulatory Surgical Centers, Others)
- 5.2.6. By Region
- 5.2.7. By Company (2025)
5.3. Market Map

6. North America Cannula Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Product
- 6.2.2. By Type
- 6.2.3. By Material
- 6.2.4. By Size
- 6.2.5. By End-Use Industry
- 6.2.6. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Cannula Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Product
    - 6.3.1.2.2. By Type
    - 6.3.1.2.3. By Material
    - 6.3.1.2.4. By Size
    - 6.3.1.2.5. By End-Use Industry
- 6.3.2. Canada Cannula Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Product
    - 6.3.2.2.2. By Type
    - 6.3.2.2.3. By Material
    - 6.3.2.2.4. By Size
    - 6.3.2.2.5. By End-Use Industry
- 6.3.3. Mexico Cannula Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Product
    - 6.3.3.2.2. By Type
    - 6.3.3.2.3. By Material
    - 6.3.3.2.4. By Size
    - 6.3.3.2.5. By End-Use Industry

7. Europe Cannula Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By Type
- 7.2.3. By Material
- 7.2.4. By Size
- 7.2.5. By End-Use Industry
- 7.2.6. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Cannula Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Product
    - 7.3.1.2.2. By Type
    - 7.3.1.2.3. By Material
    - 7.3.1.2.4. By Size
    - 7.3.1.2.5. By End-Use Industry
- 7.3.2. France Cannula Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Product
    - 7.3.2.2.2. By Type
    - 7.3.2.2.3. By Material
    - 7.3.2.2.4. By Size
    - 7.3.2.2.5. By End-Use Industry
- 7.3.3. United Kingdom Cannula Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Product
    - 7.3.3.2.2. By Type
    - 7.3.3.2.3. By Material
    - 7.3.3.2.4. By Size
    - 7.3.3.2.5. By End-Use Industry
- 7.3.4. Italy Cannula Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Product
    - 7.3.4.2.2. By Type
    - 7.3.4.2.3. By Material
    - 7.3.4.2.4. By Size
    - 7.3.4.2.5. By End-Use Industry
- 7.3.5. Spain Cannula Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Product
    - 7.3.5.2.2. By Type
    - 7.3.5.2.3. By Material
    - 7.3.5.2.4. By Size
    - 7.3.5.2.5. By End-Use Industry

8. Asia Pacific Cannula Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By Type
- 8.2.3. By Material
- 8.2.4. By Size
- 8.2.5. By End-Use Industry
- 8.2.6. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Cannula Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Product
    - 8.3.1.2.2. By Type
    - 8.3.1.2.3. By Material
    - 8.3.1.2.4. By Size
    - 8.3.1.2.5. By End-Use Industry
- 8.3.2. India Cannula Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Product
    - 8.3.2.2.2. By Type
    - 8.3.2.2.3. By Material
    - 8.3.2.2.4. By Size
    - 8.3.2.2.5. By End-Use Industry
- 8.3.3. Japan Cannula Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Product
    - 8.3.3.2.2. By Type
    - 8.3.3.2.3. By Material
    - 8.3.3.2.4. By Size
    - 8.3.3.2.5. By End-Use Industry
- 8.3.4. South Korea Cannula Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Product
    - 8.3.4.2.2. By Type
    - 8.3.4.2.3. By Material
    - 8.3.4.2.4. By Size
    - 8.3.4.2.5. By End-Use Industry
- 8.3.5. Australia Cannula Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Product
    - 8.3.5.2.2. By Type
    - 8.3.5.2.3. By Material
    - 8.3.5.2.4. By Size
    - 8.3.5.2.5. By End-Use Industry

9. Middle East & Africa Cannula Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Type
- 9.2.3. By Material
- 9.2.4. By Size
- 9.2.5. By End-Use Industry
- 9.2.6. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Cannula Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Product
    - 9.3.1.2.2. By Type
    - 9.3.1.2.3. By Material
    - 9.3.1.2.4. By Size
    - 9.3.1.2.5. By End-Use Industry
- 9.3.2. UAE Cannula Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Product
    - 9.3.2.2.2. By Type
    - 9.3.2.2.3. By Material
    - 9.3.2.2.4. By Size
    - 9.3.2.2.5. By End-Use Industry
- 9.3.3. South Africa Cannula Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Product
    - 9.3.3.2.2. By Type
    - 9.3.3.2.3. By Material
    - 9.3.3.2.4. By Size
    - 9.3.3.2.5. By End-Use Industry

10. South America Cannula Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Product
- 10.2.2. By Type
- 10.2.3. By Material
- 10.2.4. By Size
- 10.2.5. By End-Use Industry
- 10.2.6. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Cannula Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Product
    - 10.3.1.2.2. By Type
    - 10.3.1.2.3. By Material
    - 10.3.1.2.4. By Size
    - 10.3.1.2.5. By End-Use Industry
- 10.3.2. Colombia Cannula Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Product
    - 10.3.2.2.2. By Type
    - 10.3.2.2.3. By Material
    - 10.3.2.2.4. By Size
    - 10.3.2.2.5. By End-Use Industry
- 10.3.3. Argentina Cannula Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Product
    - 10.3.3.2.2. By Type
    - 10.3.3.2.3. By Material
    - 10.3.3.2.4. By Size
    - 10.3.3.2.5. By End-Use Industry

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Cannula Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Medtronic plc
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Becton Dickinson (BD) & Company
15.3. Edward Lifesciences Corporation
15.4. LivaNovaca plc
15.5. Smiths Medical MD Inc
15.6. Boston Scientific Corporation
15.7. Hindustan Syringes and Medical Devices Ltd (HMD)
15.8. Sterimedix Ltd.
15.9. Angiplast Pvt. Ltd
15.10. Sterimed Group